Fierce Biotech February 23, 2024
Andrea Park

The FDA issued a safety communication this week warning Americans that if they see a smartwatch or smart ring claiming to offer noninvasive blood sugar monitoring, the agency had nothing to do with it, thank you very much.

Though quite a few technology developers—of both the medtech and broader Big Tech varieties—are currently working toward building portable devices that can accurately measure glucose levels without having to pierce the skin, none have yet to pass the FDA’s muster.

The regulator didn’t call out any specific peddlers of the unauthorized devices in its notice, but said they’re “manufactured by dozens of companies and sold under multiple brand names.”

The notice warned that since the devices’ safety and efficacy haven’t been reviewed...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Medical Devices, Technology, Wearables
Opinion: STAT+: How will the Center for Biologics Evaluation and Research change under RFK Jr.?
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
FDA nominee pitches AI application review
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Project Optimus: The evolution of dose optimisation in oncology

Share This Article